LETTER
CH2CO), 3.66 (s, 3 H, NCH3), 7.05–7.39 (m, 4 H, H-4, H-5,
Efficient Preparation of Tricyclic Lactones
177
(hexane–ethyl acetate 9:1). IR (KBr): ν (cm–1) = 2963 (C-H),
1749 (C=O). 1H NMR (CDCl3, 200 MHz): δ (ppm) = 1.11 [s,
9 H, C(CH3)3], 3.97 (s, 3 H, NCH3), 5.26 (s, 1 H, H-1), 7.21–
7.28 (m, 1 H, H-7), 7.39–7.45 (m, 2 H, H-6, H-8), 7.68 (d,
J = 8, 1 H, H-5). 13C NMR (CDCl3, 50.3 MHz): δ (ppm) =
25.5 [CH3, C(CH3)3], 30.0 (CH3, NCH3), 35.4 [C, C(CH3)3],
87.6 (CH, C1H), 111.2 (CH, C5H), 120.8 (C, C8b), 120.9
and 122.2 (CH, C6H and C8H), 125.9 (CH, C6H), 129.9 (C,
C3a), 134.7 (C, C8a), 144.0 (C, C4a), 163.6 (C, C=O). MS:
m/z = 244 [M+ + 1]. Anal. Calcd for C15H17NO2: C, 74.0; H,
7.0; N, 5.8. Found: C, 74.3; H, 6.9; N, 5.8. 1-Benzyl-
oxymethyl-4-methyl-3-oxo-(1H)-furo[3,4-b]indole (20):
Mp: 116–118 ºC (hexane–ethyl acetate 9:1). IR (KBr): ν
(cm–1) = 2932 (C-H), 1748 (C=O). 1H NMR (CDCl3, 200
MHz): δ (ppm) = 3.90 (d, J = 6, 2 H, CH2O), 3.91 (s, 3 H,
NCH3), 4.65 (s, 2 H, CH2O), 5.70 (q, J = 6, 1 H, C1H), 7.24
(m, 1 H, Ar), 7.42 (m, 5 H, Ar), 7.46 (m, 2 H, Ar), 7.64 (d,
J = 8, 1 H, H-5). 13C NMR (CDCl3, 50.3 MHz): δ (ppm) =
30.0 (CH3, NCH3), 71.4 (CH2, CH2O), 73.8 (CH2, CH2O),
77.8 (CH, C1H), 111.1 (CH, C5H), 120.4 (C, C8b), 121.0
and 121.6 (CH, C6H and C8H), 126.0 (CH, C4′H), 127.6
(CH, C7H), 127.7 (CH, C2′H and C6′H), 128.3 (CH, C3′H
and C5′H), 128.9 (C, C3a), 134.7 (C, C8a), 137.3 (C, C1′),
144.0 (C, C4a), 162.9 (C, C=O). MS: m/z = 308 [M+ + 1].
Anal. Calcd for C19H17NO3: C, 74.3; H, 5.6; N, 4.6. Found:
C, 74.0; H, 5.7; N, 4.4. 1-(3′-(Trifluoromethane)phenyl)-
4-methyl-3-oxo-(1H)-furo[3,4-b]indole (21): Hexane–
ethyl acetate 8:2. IR (NaCl): ν (cm–1) = 2919 (C-H), 1759
(C=O), 1331 (C-F). 1H NMR (CDCl3, 200 MHz): δ (ppm) =
4.02 (s, 3 H, NCH3), 6.59 (s, 1 H, H-1), 7.19–7.60 (m, 6 H,
H-4′, H-5′, H-6′, H-6, H-7, H-8), 7.64 (d, J = 7, 1 H, H-5),
7.71 (s, 1 H, H-2′). 13C NMR (CDCl3, 50.3 MHz): δ (ppm) =
30.0 (CH3, NCH3), 79.2 (CH, C1H), 111.5 (CH, C5H), 120.2
(C, C8b), 120.8 and 121.5 (CH, C6H and C8H), 125.6 (C,
J = 288, CF3), 125.9 (CH, J = 3.6, C4′H), 126.4 (CH, C7H),
128.5 (CH, J = 3.6, C2′H), 128.9 (C, C3a), 129.4 (CH,
C5′H), 130.3 (CH, C6′H), 130.6 (C, J = 32, C3′), 131.9 (C,
J = 1, C1′), 141.0 (C, C8a), 144.4 (C, C4a), 162.7 (C, C=O).
MS: m/z = 332 [M+ + 1]. Anal. Calcd for C18H12F3NO2: C,
65.3; H, 3.7; N, 4.2. Found: C, 65.5; H, 3.9; N, 4.4. 4′-
Methyl-3-oxo-(1H)spiro{cyclo-hexyl[1,1′]furo[3,4-
b]indole} (22): Mp: 152–154 ºC (hexane–ethyl acetate 9:1).
IR (KBr): ν (cm–1): 2921 (C-H), 1749 (C=O). 1H NMR
(CDCl3, 200 MHz): δ (ppm) = 1.50–2.08 (m, 10 H, CH2),
3.93 (s, 3 H, NCH3), 7.18–7.27 (m, 1 H, H-7), 7.39–7.44 (m,
2 H, H-6, H-8), 7.68 (d, J = 8, 1 H, H-5). 13C NMR (CDCl3,
50.3 MHz):
H-6, CO2H), 7.89 (d, J = 8, 1 H, H-7), 8.43 (br s, 1 H, NH).
13C NMR (CDCl3, 50.3 MHz): δ (ppm) = 28.5 (CH2,
CH2CO), 31.4 (CH3, NCH3), 36.5 (CH2, CH2CO2H), 46.7
[CH3, N(CH3)2], 110.5 (CH, C7H), 115.0 (C, C3), 121.3
(CH, C6H), 121.4 (CH, C4H), 124.1 (CH, C5H), 121.3 (C,
C2), 124.3 (C, C3a), 136.6 (C, C7a), 160.6 (C,
CONHNMe2), 177.1 (C, CO2H), 195.5 (C, C=O). MS: m/z =
318 [M+ + 1]. Anal. Calcd for C16H19N3O4: C, 60.6; H, 6.0;
N, 13.2. Found: C, 60.3; H, 6.2; N, 13.2. 3-
(Allyloxycarbonyl)-2-(N,N-dimethylhydrazine-
carbonyl)indole (15): Hexane–ethyl acetate 2:8. IR (NaCl):
ν (cm–1) = 3200 (N-H), 1693 (COOR), 1670
[CONHN(CH3)2]. 1H NMR (CDCl3, 200 MHz): δ (ppm) =
2.77 [s, 6 H, N(CH3)2], 4.01 (s, 3 H, NCH3), 4.89 (d, J = 6, 2
H, CH2O), 5.37 (m, 2 H, CH2=CH), 6.10 (m, 1 H, CH2=CH),
6.80 (br s, 1 H, NH), 7.32 (m, 3 H, H-4, H-5, H-6), 8.15 (d,
J = 7, 1 H, H-7). 13C NMR (CDCl3, 50.3 MHz): δ (ppm) =
32.4 (CH3, NCH3), 47.3 [CH3, N(CH3)2], 65.5 (CH2, CH2O),
113.3 (CH, C7H), 118.6 (CH2, CH2=CH), 121.2 (C, C3),
122.8 (CH, C6H), 122.9 (CH, C4H), 124.4 (CH, C5H),
125.3 (C, C2), 132.1 (CH, CH2=CH), 136.8 (C, C7a), 137.2
(C, C3a), 159.6 (C, COO-), 165.8 (C, CON-). MS: m/z = 302
[M+ + 1]. Anal. Calcd for C16H19N3O3: C, 63.8; H, 6.4; N,
13.9. Found: C, 63.5; H, 6.7; N, 13.8. 3-(t-Butylcarbonyl)-
2-(N,N-dimethylhydrazinecarbonyl)-1-methylindole
(16): Mp: 149–150 ºC (hexane–ethyl acetate 3:7). IR (KBr):
ν (cm–1) = 3226 (N-H), 1662 (C=O, CONHNMe2). 1H NMR
(CDCl3, 200 MHz): δ (ppm) = 1.28 [s, 9 H, C(CH3)3], 2.67
[s, 6 H, N(CH3)2], 3.93 (s, 3 H, NCH3), 7.05–7.38 (m, 3 H,
H-4, H-5, H-6), 7.51 (d, J = 8, 1 H, H-7), 7.52 (br s, 1 H,
NH). 13C NMR (CDCl3, 50.3 MHz): δ (ppm) = 27.1 [CH3,
C(CH3)3], 31.3 (CH3, NCH3), 45.9 [C, C(CH3)3], 47.5 [CH3,
N(CH3)2], 110.2 (CH, C7H), 116.8 (C, C3), 121.0 (CH,
C6H), 121.4 (CH, C4H), 124.1 (CH, C5H), 124.2 (C, C3a),
129.6 (C, C2), 136.7 (C, C7a), 159.7 (C, CONHNMe2),
213.7 (C, C=O). MS: m/z = 302 [M+ + 1]. Anal. Calcd for
C17H23N3O2: C, 67.7; H, 7.7; N, 13.9. Found: C, 67.5; H, 7.9;
N, 13.6. 1,4-Dimethyl-3-oxo-(1H)-furo[3,4-b]indole (17):
Mp: 84–85 ºC (hexane–ethyl acetate 8:2). IR (KBr): ν
(cm–1) = 2932 (C-H), 1751 (C=O). 1H NMR (CDCl3, 200
MHz): δ (ppm) = 1.70 (d, J = 6.6, 3 H, CHCH3), 3.91 (s, 3
H, NCH3), 5.64 (q, J = 6.6, 1 H, CHCH3), 7.20–7.27 (m, 1 H,
H-7), 7.41–7.60 (m, 2 H, H-6, H-8), 7.61 (d, J = 8, 1 H, H-
5). 13C NMR (CDCl3, 50.3 MHz): δ (ppm) = 20.7 (CH3,
CHCH3), 30.0 (CH3, NCH3), 75.4 (CH, CHCH3), 111.2 (CH,
C5H), 119.8 (C, C8b), 120.6 and 120.8 (CH, C6H and C8H),
125.9 (CH, C7H), 128.5 (C, C3a), 138.2 (C, C8a), 143.9 (C,
C4a), 163.2 (C, C=O). MS: m/z = 202 [M+ + 1]. Anal. Calcd
for C12H11NO2: C, 71.6; H, 5.5; N, 7.0. Found: C, 71.5; H,
5.7; N, 6.8. 1-Hexyl-4-methyl-3-oxo-(1H)-furo[3,4-
b]indole (18): Hexane–ethyl acetate 9:1. IR (NaCl): ν
(cm–1) = 2928 (C-H), 1752 (C=O). 1H NMR (CDCl3, 200
MHz): δ (ppm) = 0.91 [d, J = 6, 3 H, (CH2)5CH3], 1.21–1.63
[m, 8 H, CH2(CH2)4CH3], 1.82–2.10 [m, 2 H,
δ (ppm) = 22.5 (CH2, C3′H and C5′H), 24.6 (CH2, C4′H),
30.0 (CH3, NCH3), 36.7 (CH2, C2′H and C6′H), 86.0 (C,
C1), 111.2 (CH, C5H), 119.8 (C, C8b), 120.7 and 121.1
(CH, C6H and C8H), 125.7 (CH, C7H), 128.2 (C, C3a),
138.2 (C, C8a), 143.9 (C, C4a), 163.2 (C, C=O). MS: m/z =
256 [M+ + 1]. Anal. Calcd for C16H17NO2: C, 75.3; H, 6.7;
N, 5.5. Found: C, 75.2%, H, 6.9; N, 5.2. 1′-Benzyl-4-
methyl-3-oxo-(1H)-spiro{furo[3,4-b]indole-1,4′-
CH2(CH2)4CH3], 3.94 (s, 3 H, NCH3), 5.58 (q, J = 6, 1 H,
C1H), 7.23–7.46 (m, 3 H, H-6, H-7, H-8), 7.62 (d, J = 8, 1
H, H-5). 13C NMR (CDCl3, 50.3 MHz): δ (ppm) = 14.0
[CH3, (CH2)5CH3], 22.5 [CH2, (CH2)5CH3], 24.8 [CH2,
(CH2)5CH3], 29.0 [CH2, (CH2)5CH3], 30.0 (CH3, NCH3),
31.6 [CH2, (CH2)5CH3], 34.6 [CH2, (CH2)5CH3], 79.4 (CH,
C1H), 111.2 (CH, C5H), 120.1 (C, C8b), 120.8 and 121.0
(CH, C6H and C8H), 125.8 (CH, C7H), 128.8 (C, C3a),
137.0 (C, C8a), 144.0 (C, C4a), 163.4 (C, C=O). MS: m/z =
272 [M+ + 1]. Anal. Calcd for C17H21NO2: C, 75.2; H, 7.8;
N, 5.2. Found: C, 75.1; H, 7.7; N, 4.9. 1-t-Butyl-4-methyl-
3-oxo-(1H)-furo[3,4-b]indole (19): Mp: 171–173 ºC
piperidine} (23): Hexane–ethyl acetate 8:2. IR (NaCl): ν
(cm–1) = 1755 (C=O). 1H NMR (CDCl3, 200 MHz): δ (ppm)
= 1.87 (d, J = 12.8, 2 H, Hax-3′ and Hax-5′), 2.47 (dt,
J = 11.8, J′ = 4.4, 2 H, Heq-3′ and Heq-5′), 2.70 (dt, J = 11.6,
J′ = 2, 2 H, Hax-2′ and Hax-6′), 3.01 (d, J = 11.2, 2 H, Heq-2′
and Heq-6′), 3.74 (s, 2 H, CH2Ar), 3.92 (s, 3 H, NCH3), 7.11–
7.42 (m, 8 H, H-6, H-7, H-8, H-2′′, H-3′′, H-4′′, H-5′′ and H-
6′′), 7.63 (d, J = 8, 1 H, H-5). 13C NMR (CDCl3, 50.3 MHz):
δ (ppm) = 30.1 (CH3, NCH3), 35.7 (CH2, C3′ and C5′), 49.2
(CH2, C2′ and C6′), 62.5 (CH2, CH2Ar), 82.9 (C, C1), 111.2
(CH, C5H), 119.6 (C, C8b), 120.8 and 121.0 (CH, C6H and
C8H), 126.0 (CH, C7H), 127.5 (CH, C4′′H), 128.1 (C, C3a),
Synlett 2003, No. 2, 173–178 ISSN 0936-5214 © Thieme Stuttgart · New York